ADHD and depression: investigating a causal explanation by Riglin, Lucy et al.
Psychological Medicine
cambridge.org/psm
Original Article
Cite this article: Riglin L et al (2020). ADHD
and depression: investigating a causal
explanation. Psychological Medicine 1–8.
https://doi.org/10.1017/S0033291720000665
Received: 4 September 2019
Revised: 10 January 2020
Accepted: 4 March 2020
Key words:
ADHD; ALSPAC; causal; depression;
longitudinal; Mendelian randomization
Author for correspondence:
Lucy Riglin, E-mail: riglinl@cardiff.ac.uk and
Anita Thapar, E-mail: thapar@cardiff.ac.uk
© The Author(s) 2020. Published by Cambridge
University Press. This is an Open Access article,
distributed under the terms of the Creative
Commons Attribution licence (http://
creativecommons.org/licenses/by/4.0/), which
permits unrestricted re-use, distribution, and
reproduction in any medium, provided the
original work is properly cited.
ADHD and depression: investigating
a causal explanation
Lucy Riglin1 , Beate Leppert2, Christina Dardani2,3, Ajay K. Thapar1,
Frances Rice1, Michael C. O’Donovan1, George Davey Smith2, Evie Stergiakouli2,4,
Kate Tilling2 and Anita Thapar1
1Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and
Genomics, Cardiff University, Cardiff, UK; 2Population Health Sciences, Bristol Medical School and MRC Integrative
Epidemiology Unit, University of Bristol, Bristol, UK; 3Centre of Academic Mental Health, Bristol Medical School,
University of Bristol, Bristol, UK and 4Oral and Dental Sciences, University of Bristol, Bristol, UK
Abstract
Background. Attention-deficit hyperactivity disorder (ADHD) is associated with later depres-
sion and there is considerable genetic overlap between them. This study investigated if ADHD
and ADHD genetic liability are causally related to depression using two different methods.
Methods. First, a longitudinal population cohort design was used to assess the association
between childhood ADHD (age 7 years) and recurrent depression in young-adulthood (age
18–25 years) in N = 8310 individuals in the Avon Longitudinal Study of Parents and
Children (ALSPAC). Second, two-sample Mendelian randomization (MR) analyses examined
relationships between genetic liability for ADHD and depression utilising published Genome-
Wide Association Study (GWAS) data.
Results. Childhood ADHD was associated with an increased risk of recurrent depression in
young-adulthood (OR 1.35, 95% CI 1.05–1.73). MR analyses suggested a causal effect of
ADHD genetic liability on major depression (OR 1.21, 95% CI 1.12–1.31). MR findings
using a broader definition of depression differed, showing a weak influence on depression
(OR 1.07, 95% CI 1.02–1.13).
Conclusions. Our findings suggest that ADHD increases the risk of depression later in life and
are consistent with a causal effect of ADHD genetic liability on subsequent major depression.
However, findings were different for more broadly defined depression.
Attention-deficit hyperactivity disorder (ADHD) is a common, childhood-onset neurodeve-
lopmental disorder that frequently co-occurs with other neuropsychiatric disorders (Jensen
& Steinhausen, 2015; Thapar & Cooper, 2016). There is growing recognition that ADHD is
commonly associated with depression, which typically onsets later, with an estimated increase
in risk for depression of 6.5-fold within the first year of ADHD diagnosis (Gundel, Pedersen,
Munk-Olsen, & Dalsgaard, 2018).
One explanation is that ADHD causes depression. For example, ADHD could elicit stressful
environmental exposures such as discordant relationships (Harold et al., 2013; Lifford, Harold,
& Thapar, 2009), peer-victimization (Schoeler et al., 2019; Sonuga-Barke & Taylor, 2015) and
poor academic attainment (Loe & Feldman, 2007), which in turn increase risk of depression
(Schoeler, Duncan, Cecil, Ploubidis, & Pingault, 2018; Thapar, Collishaw, Pine, & Thapar,
2012). A causal explanation implies that treatment of ADHD will reduce risk of depression.
Consistent with this, a quasi-experimental national registry study found that individuals
with ADHD had a 20% lower rate of depression when receiving ADHD medication compared
to when they were not, and suggested that ADHD medication was associated with a decreased
long-term risk of depression (Chang, D’Onofrio, Quinn, Lichtenstein, & Larsson, 2016).
Twin studies, in contrast, suggest that ADHD and depression co-occurrence is largely
explained by shared genetic factors (approximately 70%: Faraone & Larsson, 2019). Also, a
recent Genome-Wide Association Study (GWAS) of ADHD reported extensive genetic correl-
ation with other psychiatric disorders, the strongest of which was with depression (major
depressive disorder rg = 0.42, depressive symptoms rg = 0.45) (Demontis et al., 2019).
Genetic overlap could mean that alleles manifest as different disorders, either in different peo-
ple (contributing to ADHD in one person and depression in another) or at different times. For
example, the same genetic risks could manifest as ADHD in early-life and depression later: a
type of heterotypic continuity (Rutter, Kim-Cohen, & Maughan, 2006). Alternative explana-
tions which would inflate genetic overlap estimates include overlapping symptoms that con-
tribute to each phenotype (e.g. concentration problems) or unmeasured confounders.
Distinguishing between these explanations is important because they have different preven-
tion and treatment implications. Here, we investigated the relationship between ADHD and
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depression using two study designs (Gage, Munafo, & Davey
Smith, 2016; Thapar & Rutter, 2019). The rationale was that if
both designs showed evidence in favour of an effect of ADHD
on depression, this would strengthen the conclusion that
ADHD causes later depression (Lawlor, Tilling, & Davey Smith,
2016). First, to examine whether ADHD preceded depression,
we directly examined the association between ADHD in child-
hood and later depression in young-adulthood in a longitudinal
population-based cohort. If childhood ADHD has a potentially
causal effect on depression, we would expect to see higher levels
of young-adult depression in those with versus without childhood
ADHD. Prospective designs reduce the problem of reverse caus-
ation although longitudinal association can arise from unmeas-
ured confounding including shared risk factors. Thus, we also
used two-sample Mendelian randomization (MR) as an alterna-
tive approach to causal inference because provided certain
assumptions are met, it is less likely to be affected by confounding
(Davey Smith & Hemani, 2014). MR tests whether genetic liability
to ADHD causes depression when shared pleiotropic effects
between ADHD and depression are taken into account. Genetic
instruments were selected from large GWAS data as proxies for
exposure (ADHD) and outcome (depression).
Method
Longitudinal analyses
Sample
Mental health data were used from the Avon Longitudinal Study
of Parents and Children (ALSPAC), a well-established prospect-
ive, longitudinal birth cohort study. Details of this study are pro-
vided in the online Supplementary Material. Individuals were
included in our analyses when data were available on ADHD in
childhood (see below): N = 8310 (56% of those alive at 1 year).
ADHD (exposure)
ADHD in childhood was measured using the well-validated, five-
item parent-rated ADHD subscale of the Strengths and Difficulties
Questionnaire (SDQ) (Goodman, 1997) (range 0–10) at age
81 months (roughly age 7 years) (online Supplementary
Table S1a). Individuals were coded as having ‘ADHD’ if they met
the >7 recommended cut-point (Goodman, 1997). Total ADHD
scores were also computed. Sensitivity analyses were conducted
using ADHD diagnosis and more broadly defined ADHD (high
symptoms at ages 7, 8, 9 or 11 years) (online Supplementary
Material page 3). To investigate the extent to which observed
ADHD–depression association could be due to the persistence of
ADHD symptoms into young-adulthood, we assessed ‘adult
ADHD’ using self-reported SDQ ADHD data at age 25 years.
There is no research to guide appropriate cut-points for adult
ADHD. In line with DSM-5 guidance that fewer symptoms are
needed for an ADHD diagnosis in adulthood, we used one point
less for the cut-point (the recommended ADHD cut-point for
SDQ self-reports is >6, so we used >5 for adult self-reports).
Individuals were coded as having ADHD that persists in adult
life if they met the relevant cut-points at ages 7 and 25.
Depression (outcome)
Depression was measured at five time-points from age 18 years
(in young-adulthood), using the 13-item self-rated Short Moods
and Feeling Questionnaire (sMFQ) (Angold et al., 1995) (range
0–26): at ages 18, 21, 22, 23 and 25 years (online
Supplementary Table S1b). The sMFQ is a well-validated, widely
used measure which has been shown to be a valid diagnostic tool
for detecting major depressive disorder in community samples
(Angold et al., 1995; Thapar & McGuffin, 1998; Turner,
Joinson, Peters, Wiles, & Lewis, 2014). We focused on depression
after age 18 years as our outcome in the longitudinal analyses to
obtain similarity to the depression phenotype in the GWAS from
which we derived our instruments for MR (predominantly parti-
cipants aged ⩾18 years; see MR analyses).
Single episodes of depression are common (Mojtabai, Olfson,
& Han, 2016) and depression is highly heterogeneous. For
example, depression can be defined broadly (e.g. self-reported
responses to one or two questions) as well as more strictly (e.g.
DSM-defined major depression or recurrent depression). Recent
findings in pre-peer-reviewed format (Cai et al., 2019) suggest
that the genetic architecture of broad depression (e.g. from UK
biobank; Howard et al., 2019) is not the same as more narrowly
defined depression (e.g. recurrent female depression; Converge
consortium, 2015). Twin and family studies also suggest that nar-
rowly defined depression is more familial and heritable
(Glowinski, Madden, Bucholz, Lynskey, & Heath, 2003; Klein,
Shankman, Lewinsohn, Rohde, & Seeley, 2004). In the present
analysis, we therefore selected the more narrow outcome of recur-
rent depression in young-adulthood for those who met the recom-
mended >11 sMFQ cut-point (Thabrew, Stasiak, Bavin,
Frampton, & Merry, 2018) at least twice in adulthood (⩾18
years) to approximate the depression outcome for the GWAS
used in our initial MR analysis (see below). Single time-point
total depressive symptom scores were also computed. To investi-
gate whether the observed association between ADHD and
depression in young-adulthood could be due to the persistence
of childhood depression, we used previous self-reports and classi-
fied ‘childhood depression’ based on meeting the sMFQ cut-point
at ages 10 or 12 years.
Covariates
Sex, early social adversity (parent home ownership and crowding
during pregnancy), maternal education and maternal prenatal
depression were included as potential confounders for the longi-
tudinal analyses.
Analyses
There were 8310 individuals with ADHD data at age 7, of these
57% (N = 4771) had depression data for at least one time point
(full details in online Supplementary Material). Primary analyses
were conducted using multiple imputation (MI) by chained equa-
tions, including all those with ADHD data (N = 8310) to minim-
ize bias from missing depression data (Lawlor et al., 2016; White,
Royston, & Wood, 2011). Sensitivity analyses were conducted
using MI for the full ALSPAC dataset (i.e. including those without
age 7 ADHD data), using inverse probability weighting (IPW)
(Seaman & White, 2013) and using listwise deletion to investigate
the impact of missing data. Full details of the imputation and IPW
models are given in the online Supplementary Material.
Mendelian randomization
Genetic data
For primary analyses examining the effect of ADHD genetic
liability on depression, genetic data were used from GWAS of
individuals with European ancestry for ADHD (N = 53 293:
Demontis et al., 2019) and major depression (MD) (N = 138
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884: Wray et al., 2018, excluding 23andMe and UK Biobank,
described in Howard et al., 2019). These are described in more
detail in the online Supplementary Material.
Additional analyses were conducted using a larger, more
recent depression GWAS (N = 500 199: Howard et al., 2019)
which included a ‘broad depression’ phenotype based on self-
reported help-seeking behaviour for nerves, anxiety, tension or
depression (N = 361 315: 72% of the GWAS sample).
Previously reported genetic correlations with ADHD are rg =
0.42 (S.E. = 0.03) for MD (Demontis et al., 2019) and rg = 0.39
(S.E. = 0.10) for broad depression (Howard et al., 2019).
Analyses
Two-sample MR utilizes genetic variants from GWAS as instru-
mental variables (proxies for the exposure). These genetic proxies
should satisfy three main assumptions: (i) strong association with
the exposure, (ii) no association with confounders of the expos-
ure–outcome association, (iii) association with the outcome exclu-
sively via the exposure (Bowden et al., 2016). Since genetic
variants are randomly assorted at meiosis and fixed at conception,
this method is more robust to confounding than conventional
observational studies. Variants therefore differ regarding exposure
and suffer from little confounding, providing some analogy with
randomized control trial groups.
Genetic variants (single-nucleotide polymorphisms, SNPs)
were extracted from the relevant GWAS using a p value threshold
of 5 × 10−08. SNPs were pruned to be in linkage equilibrium (r2 <
0.001). Where SNPs were missing in the outcome GWAS, linkage
disequilibrium proxies (r2 = 0.8 within 250 kb) were used. Data
were harmonized across the exposure/outcome datasets and palin-
dromic SNPs were excluded: details of the included SNPs are
shown in online Supplementary Tables S2 and S3.
Three MR approaches were conducted to estimate the expos-
ure–outcome effect because these have different assumptions:
inverse-variance weighted (IVW) linear regression, a weighted
median approach and MR-Egger regression. IVW assumes that
all instruments are valid and that there is no horizontal pleiotropy
(i.e. SNPs are associated with the outcome exclusively via the
exposure). The weighted median method estimates the median
(rather than the mean) causal estimate and is therefore robust
to 50% of the genetic variants being invalid. Finally, MR-Egger
regression relaxes the third assumption (i.e. no horizontal plei-
otropy), by allowing the intercept of the SNP–exposure and
SNP–outcome regression to be non-zero; the intercept thus pro-
vides an estimate of horizontal pleiotropy and the slope provides
an estimate of the causal effect of an exposure on an outcome
accounting for pleiotropic effects. MR-Egger regression is there-
fore less well powered but is robust when 100% of genetic variants
have pleiotropic effects, conditional on the assumption that the
pleiotropic effects are distributed independently of instrument
strength (instrument strength independent of direct effect;
InSIDE) (Bowden et al., 2016) (and the assumption that the
instruments are measured without error: NOME assumption).
Instrument strength, heterogeneity and outliers: for IVW ana-
lyses, instrument strength was assessed using the F statistic (F < 10
suggests results may suffer from weak instrument bias) and het-
erogeneity in the SNP–exposure/SNP–outcome association
using Cochrane’s Q (Bowden et al., 2016). For MR-Egger analyses,
heterogeneity was assessed by I2GX values (I
2
GX < 90% suggests a
potential violation of the NOME assumption): simulation
extrapolation (SIMEX)-adjusted MR-Egger was used to provide
bias-adjusted estimates when appropriate (Bowden et al., 2016).
Radial plots were used to check for potential outliers (individual
variants) between IVW and MR-Egger estimates (Bowden et al.,
2018).
Sensitivity analyses were conducted using Steiger filtering to
determine the direction of causal effect for each SNP, by checking,
for example, that ADHD SNPs explain more variation in ADHD
than depression (Hemani, Tilling, & Davey Smith, 2017). In-line
with recommendations, we used bidirectional MR to assess
reverse causation (the effect of depression genetic liability on
ADHD) by repeating analyses with depression genetic variants
as the exposure and ADHD genetic variants as the outcome
(Davey Smith & Hemani, 2014). MR analyses were conducted
using the TwoSampleMR package version 0.4.17 for R.
Results
Longitudinal analyses: association between childhood ADHD
and adult depression
Of those included in our sample, 6.4% (N = 530) scored above the
ADHD cut-point in childhood (age 7) and 26.9% had recurrent
depression in young-adulthood (high depression symptoms at
least twice in young-adulthood). Table 1 shows current rates of
depression at each assessment in young-adulthood, as well as
demographic information for those with and without childhood
ADHD. Approximately 32.7% of those with childhood ADHD
had recurrent depression compared to 26.5% of those without
ADHD. Conversely, of those with recurrent depression in young-
adulthood, approximately 7.8% had childhood ADHD compared
to 5.9% in those without.
ADHD in childhood was associated with an increased risk of
having recurrent depression in young-adulthood: OR 1.35, 95%
CI 1.05–1.73, p = 0.02. This was robust to controlling for sex,
early adversity, maternal education and maternal depression
(OR 1.38, 95% CI 1.07–1.79, p = 0.01).
ADHD defined as a continuous trait (total symptom scores)
was also associated with later recurrent depression (OR 1.06,
95% CI 1.03–1.09, p = 1 × 10−05). The association with recurrent
depression was similar when ADHD was defined as ADHD diagno-
sis and more broadly defined ADHD (see online Supplementary
Material page 3). Finally, investigating associations with continuous
depressive symptom scores at single time-points found childhood
ADHD to be associated with higher depression symptoms in young-
adulthood, but the evidence was weaker than when investigating
association with recurrent depression (online Supplementary
Table S4).
Sensitivity analyses to assess the impact of missing ADHD data
using MI for the full ALSPAC sample (i.e. including those without
age 7 ADHD data) and using IPW found a similar pattern of
results although with much wider confidence intervals when
using IPW (see online Supplementary Material). Analyses using
listwise deletion did not find evidence of an association between
childhood ADHD and recurrent depression in young-adulthood,
likely reflecting bias due to non-random attrition, although con-
fidence intervals were wide and overlapped those from the MI
analyses (see online Supplementary Material page 2 and
Supplementary Table S5).
The contribution of childhood depression
Approximately 7.5% of the sample had childhood depression
(15.5% of those with childhood ADHD and 15.2% of those
with recurrent depression in young-adulthood). Childhood
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ADHD was associated with an increased likelihood of recurrent
depression in young-adulthood for those without childhood
depression (OR 1.28, 95% CI 0.96–1.71, p = 0.09). There was no
evidence that ADHD conferred an additional risk for young-adult
depression in those who already had depression in childhood (OR
0.88, 95% CI 0.48–1.62, p = 0.69), although the sample size was
small.
The contribution of adult ADHD
Finally, approximately 2.2% of the sample had adult (persistent)
ADHD (34.1% of those with childhood ADHD). Those with adult
ADHD had a higher proportion of recurrent depression in young-
adulthood compared to those with childhood ADHD only (47.5%
compared to 26.4%): OR 2.69, 95% CI 1.61–4.50, p = 2 × 10−04.
The association with later recurrent depression for those whose
childhood ADHD did not persist to adulthood was greatly attenu-
ated: OR 0.93, 95% CI 0.67–1.29, p = 0.66.
Conversely, those with recurrent depression in young-
adulthood were also at an increased risk of having adult ADHD
(3.4% compared to 1.6% in those without recurrent depression
in young-adulthood): OR 2.51, 95% CI 1.68–3.75, p = 8 × 10−06.
Mendelian randomization
MR results are summarized in Table 2. We did not find evidence
of weak instrument bias for IVW analyses (ADHD F = 31.13, MD
F = 34.28). MR-Egger indicated potential violation of the NOME
assumption (ADHD I2GX = 38%) so SIMEX-adjusted MR-Egger
regression were conducted as a sensitivity analysis.
For each unit increase in log-odds genetic liability of ADHD,
there was evidence consistent with an approximately 21%
increased risk in odds of MD, as suggested by the IVW (OR
1.21, 95% CI 1.12–1.31) with very little evidence of heterogeneity
(Q = 9.22, df = 9, p = 0.42). This association was consistent across
the different MR approaches (weighted median OR 1.20, 95% CI
1.08–1.33; SIMEX-adjusted MR-Egger OR 1.22, 95% CI 1.13–
1.31) and there was very little evidence of pleiotropy
(SIMEX-adjusted MR-Egger intercept OR 1.00, p = 0.25).
Analyses in the reverse direction (odds of ADHD for each unit
increase in log-odds genetic liability of MD) found less consistent
evidence of association (IVW OR 1.80, 95% CI 0.85–3.82;
weighted median OR 1.26, 95% CI 0.85–1.86) with evidence of
heterogeneity (Q = 13.50, df = 2, p = 1 × 10−03) although analyses
were limited by the small number of available SNPs for MD (N
= 3: see Table 2).
Results using GWAS findings for a broader depression pheno-
type are shown in Table 2. We did not find evidence of weak
instrument bias for IVW analyses (broad depression F = 37.87).
Again, MR-Egger analyses indicated a potential violation of the
NOME assumption (ADHD I2GX = 38%, broad depression I
2
GX =
24%) so SIMEX-adjusted MR-Egger regression were conducted.
We found weaker evidence for an impact of ADHD genetic
liability on broad depression, consistent with an approximately
7% increase in the odds of broad depression per log odd increase
in genetic liability to ADHD, in the presence of horizontal plei-
otropy (SIMEX-adjusted MR-Egger slope OR 1.07, 95% CI
1.02–1.13; intercept OR 1.01, p = 2 × 10−03). Using the broader
depression GWAS for MR analysis, association in the reverse dir-
ection suggested an approximately 79% increase in the odds of
ADHD per log odd increase in genetic liability to broad depres-
sion (IVW OR 1.79, 95% CI 1.36–2.36) with evidence of hetero-
geneity (Q = 117.78, df = 39, p = 8 × 10−10). This was consistent
across the different MR approaches (weighted median OR 1.65,
95% CI 1.28–2.12; SIMEX-adjusted MR-Egger OR 1.76, 95% CI
1.32–2.34) with little evidence of horizontal pleiotropy
(SIMEX-adjusted MR-Egger intercept OR 1.00, p 0.30).
Sensitivity analyses
Steiger filtering showed evidence consistent with the causal direc-
tion being correct for all the ADHD SNPs. There was evidence
that one of the three MD SNPs and 12 of the 40 broad depression
SNPs did not meet this criterion (online Supplementary Table S3).
Removing these SNPs revealed the same pattern of results as when
they were included (online Supplementary Table S6).
Discussion
This study used two different designs, a longitudinal population
cohort design and Mendelian randomization (MR) to investigate
a possible causal relationship between ADHD and depression.
Previous work has observed association and genetic overlap
between ADHD and depression (Demontis et al., 2019) but it is
unclear from these studies whether this is due to the same set
of risks manifesting as different disorders in different people, at
different ages, or because ADHD causes depression (or both).
Our longitudinal analyses found evidence in favour of an associ-
ation between childhood ADHD and subsequent depression in
adult life. Findings of MR analyses were different depending on
which depression GWAS was used. Using variants from the
GWAS of major depression (MD), we observed a causal effect
of ADHD genetic liability on depression. However, when using
Table 1. Demographic information and prevalence of depression in adult life
assessed using the sMFQ in those with and without ADHD in ALSPAC
With ADHD
(N = 530)
Without ADHD
(N = 7780)
Demographics
Age (months)a 81.54 (81.44–81.65) 81.44 (81.41–81.47)
Female sex 31.11% (27.32–35.21) 49.83% (48.72–50.94)
Birth weight (kg) 3.34 (3.30–3.39) 3.44 (3.43–3.45)
Maternal age at
childbirth (years)
28.36 (27.94–28.78) 28.98 (28.88–29.08)
Maternal education:
university degree
10.69% (8.04–13.34) 15.60% (14.79–16.42)
Parental home
ownership
73.86% (70.00–77.71) 83.56% (82.71–84.41)
Depression
Age 18 25.86% (20.31–31.41) 21.32% (19.98–22.66)
Age 21 21.25% (16.13–26.38) 15.88% (14.60–17.16)
Age 22 21.71% (16.83–26.59) 17.60% (16.36–18.83)
Age 23 29.10% (23.59–34.62) 22.88% (21.53–24.23)
Age 25 27.84% (22.47–33.21) 22.45% (21.13–23.76)
Recurrent
depression
32.72% (27.37–38.05) 26.47% (25.15–27.80)
sMFQ, short Moods and Feelings Questionnaire; ADHD, attention-deficit/hyperactivity
disorder at age 7 years; ALSPAC, the Avon Longitudinal Study of Parents and Children.
95% confidence intervals in parentheses.
aAge at childhood ADHD assessments, N = 8266.
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depression variants identified from a larger GWAS of a broader
definition of depression, the findings supported the reverse direc-
tion of causality whereby depression genetic liability caused
ADHD.
In our population cohort, we found that childhood ADHD was
associated with an increased risk of recurrent depression in
young-adulthood. This association was held when controlling
for sex, adversity, maternal education and maternal depression.
These UK cohort findings are consistent with Scandinavian
patient registry data which found that children diagnosed with
ADHD were approximately six times as likely to have depression
within 1 year of ADHD diagnosis and twice as likely within 5
years, compared to children without ADHD (Gundel et al.,
2018). Ours is the first study to our knowledge that has used a
large prospective population-based sample to examine associa-
tions between childhood ADHD and recurrent depression over
a decade later, and extends previous work in this sample showing
an association between childhood ADHD and adolescent depres-
sion (Eyre et al., 2019). Our findings suggest that this association
is not driven by childhood depression, but rather that children
with ADHD develop subsequent depression. We observed that
much of this association was explained by the continuation of
ADHD into adult life. This has important implications for
those assessing and treating adults with ADHD and for clinicians
to be mindful of possible undetected depression in adults with
ADHD (in whom we found nearly half had recurrent depression).
The results suggesting that those whose ADHD symptoms per-
sist into adulthood are at particular risk of having depression are
consistent with previous work suggesting poorer outcomes at age
18 years for those with persistent compared to remitted ADHD
(Agnew-Blais et al., 2018). However, it is important to note that
ADHD by itself is not a strong risk factor for adult depression:
reducing ADHD symptoms may prevent subsequent depression,
but many individuals will develop depression for reasons not
explained by the presence of ADHD. For example, while approxi-
mately 54% of those with ‘adult ADHD’ had depression in young-
adulthood, only 2.6% of those with depression in young-
adulthood had adult ADHD. The very high rate of ‘recurrent
depression’ by age 25 years is surprising. However, rates of depres-
sion in young people have risen in recent years (Mojtabai et al.,
2016) and it is possible that this was especially well captured in
ALSPAC because the sMFQ was administered so frequently.
While those with ADHD are at increased risk for later depres-
sion, causality cannot be inferred by a longitudinal observational
design alone. Using two-sample MR, we assessed the influence of
ADHD genetic liability, rather than directly assessed ADHD, on
depression by using genetic variants as instrumental variables.
Findings from the MR analyses were not clear-cut however and
depended on which depression GWAS dataset was used. Using
data from the GWAS of more narrowly defined MD, we found
evidence in support of causal effects of ADHD genetic liability
on MD. We found little evidence for an association in the reverse
direction, although these analyses were underpowered due to the
limited number of available SNPs. The largest GWAS of depres-
sion to date utilized a much broader depression phenotype
(Howard et al., 2019): MR analyses using instruments from this
GWAS (40 SNPs) had increased power to detect effects compared
to those for MD (10 SNPs). Findings for broad depression were
less consistent than for MD, with only weak evidence of ADHD
genetic liability influencing depression but in the presence of
horizontal pleiotropy (suggesting that ADHD genetic variants
also impact on broad depression via routes independent ofTa
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ADHD phenotypic manifestations). However, MR analysis in the
reverse direction suggested broad depression genetic liability
influences ADHD. ADHD precedes the onset of depression, but
this finding could reflect parental factors, whereby parental
(broad) depression genetic liability impacts on offspring ADHD.
An alternative explanation, given that broad depression genetic
liability shows overlap with a range of different psychiatric traits,
is that it might influence early temperament measures that in turn
are causally related to ADHD.
The extent to which genetic findings and MR based on minim-
ally phenotyped broad depression phenotypes can be generalized
to more strictly defined depression diagnosis has been contested
(Cai et al., 2019). Our findings add to this. The GWAS from
which our broad depression SNPs were defined found a genetic
correlation of 0.87 between the broader phenotype of self-
reported help-seeking behaviour in UK Biobank and the primar-
ily clinically defined major depressive disorder phenotype used in
previous work (Howard et al., 2019). This suggests there are
shared genetic factors between MD and more broadly defined
depression, consistent with twin research (Kendler et al., 2019).
However, twin studies have also suggested possible differences
in the genetic epidemiology of depression based on differing levels
of severity, whereby genetic factors may explain less variance for
broader, less severe depression phenotypes (Glowinski et al.,
2003). Moreover, recent work in pre-peer-reviewed format sug-
gests that depression GWAS based on ‘minimal phenotyping’
may result in the identification of gene variants that are non-
specific to depression, that overlap more with other psychiatric
traits and disorders (Cai et al., 2019). This could explain why
we observe differences in our MR findings depending on which
depression GWAS was used.
Taking the longitudinal and MR findings for MD together in
combination with previous quasi-experimental work (Chang
et al., 2016), our findings converge in favour of the hypothesis
that ADHD influences the risk of later depression. However,
until additional, larger GWAS are conducted, caution is needed
given the inconsistent MR results using GWAS for broad versus
major depression. These findings suggest that effective on-going
treatment of ADHD may reduce the risk of future depression in
those with ADHD. This might be an especially important consid-
eration in the transition from child and adolescent mental health
services to adult services at age 18 when many with ADHD get
lost to follow-up (Young et al., 2016) and coincides with an
increase in rates of MD.
In triangulating findings between methods, it is important to
compare possible biases. For observational studies, the main likely
sources of bias are residual confounding, reverse causality, mis-
classification and non-random missingness (Lawlor et al., 2016).
Our phenotypic analyses are unlikely to suffer from reverse caus-
ality given the early onset of ADHD. When we investigated the
effect of possible confounders, our findings were robust to the
inclusion of sex, adversity, maternal education and maternal
depression as covariates. However, unmeasured confounding is
always a potential problem in observational studies (Thapar &
Rutter, 2019). Also, ALSPAC like many longitudinal samples suf-
fers from non-random attrition: individuals at elevated risk of
psychopathology are more likely to drop-out of the study
(Taylor et al., 2018). We used MI to try to minimize the effect
of missingness, although this is only valid if the data are missing
at random (missingness is independent of the unobserved missing
data, given the variables in the imputation model) and the imput-
ation model is correctly specified.
In contrast, the main source of bias for MR is horizontal plei-
otropy (genetic variants for the exposure being related to the out-
come via routes other than the exposure) (Lawlor et al., 2016).
MR analyses for ADHD and MD did not find strong evidence
of horizontal pleiotropy suggesting that this bias is unlikely to
be substantial, although these analyses were limited due to the
variants available. We did find evidence of horizontal pleiotropy
for association with broad depression genetic liability. Other
sources of bias include population stratification, which will have
been minimized by our use of European ancestry GWAS results,
although the lack of diversity with respect to ancestral populations
and ethnicity (in both methods) may limit the generalizability of
our findings. Another assumption of two-sample MR is that the
two samples come from the same underlying population: the
ADHD and depression GWAS samples come from different
populations in that they primarily use child and adult cases
respectively, which may affect the results. Finally, we did not
find evidence of weak instrument bias for IVW analyses, which
will have been minimized by the use of large GWAS (and
would bias towards the null; Lawlor et al., 2016). Future work
should examine the consistency of findings across different emer-
ging techniques that use genetic data to test causality (O’Connor
& Price, 2018). It is also important to note when comparing
methods, that our longitudinal analyses focussed on ADHD at
age 7 (with secondary analyses including age 25 ADHD data),
whereas MR measures lifetime exposure. The causal effect of
ADHD on depression estimated by MR could be driven by the
persistence of ADHD across the lifespan, which is consistent
with our observation of stronger association with depression for
ADHD that persisted into adult life.
Both methods were limited by the measures used. The measure
used in sensitivity analyses of adult ADHD is yet to be validated
for this age-group: this needs further research given the import-
ance of using consistent measures across time. The measures
used in both of our methods also meant that we were unable to
investigate whether inattention or hyperactivity–impulsivity
symptoms are more likely to lead to later depression.
In conclusion, we used two methods to investigate a possible
causal impact of ADHD and ADHD genetic liability on depres-
sion. Our longitudinal analyses highlight ADHD as a risk factor
for depression in young-adulthood and MR analyses supported
a causal effect of ADHD on MD although findings were different
depending on the definition of depression. Taken together, clin-
ical follow-up studies, one quasi-experimental design and this
MR study and cohort design, converge in suggesting that
ADHD may have a causal effect on depression. This suggests
that effective treatment of ADHD might help prevent the develop-
ment of depression for some, especially when ADHD persists into
adulthood, but that it is unlikely to consistently prevent the devel-
opment of depression for all.
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S0033291720000665.
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